Lilly’s acquisition of Nexus plant tops list of year’s largest M&A deals

One of the largest mergers or acquisitions in the past year brought a new corporate citizen to southeastern Wisconsin and with it, billions of dollars in additional planned investment. Indianapolis-based pharmaceutical giant Lilly paid $924.7 million, net of cash acquired, to acquire the entities that owned the 100,000-square-foot Nexus Pharmaceutical facility in Pleasant Prairie, according to securities filings. The price included $108.5 million for property and equipment and $816.5 million for goodwill, attributed to “the synergies between the manufacturing capabilities of the site and our products as well as the assembled workforce of the site.” The deal was announced in April. In December, Lilly announced plans for a $3 billion expansion in Pleasant Prairie to bolster injectable product manufacturing.

Other M&A deals during the year included recognizable names and a number of startups that garnered significant attention in recent years. Here is a sampling of some of the major deals covered by BizTimes in the past year:

Sign up for the BizTimes email newsletter

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

What's New

BizPeople

Sponsored Content

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
BizTimes Milwaukee

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.